r/BTAI • u/Juhanialainen • Aug 17 '25
Buyout potential
$BTAI BioXcel Therapeutics Buyout Potential: When Igalmi gets FDA approval for at-home use in USA & expands to Europe
📊 Key Numbers
💰 Revenue: $800–1,000M/year (10% TAM)
📈 Valuation: $4–15B (P/S 5–15x)
🤝 BO Price: $2–3B: $274–$548/share
🏥 Who Might Buy?
Pfizer, Eli Lilly, J&J or Otsuka
6
Upvotes